SILO PHARMA, INC. Increase (Decrease) in Inventories
SILO PHARMA, INC. (SILO) reported Increase (Decrease) in Inventories of $22.12 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2021-08-13
- SILO PHARMA, INC. increase (decrease) in inventories for the quarter ending 2021-06-30 was $10.94K.
- SILO PHARMA, INC. increase (decrease) in inventories for the quarter ending 2021-03-31 was $11.18K.
- SILO PHARMA, INC. increase (decrease) in inventories for the quarter ending 2020-06-30 was -$975.00.
- SILO PHARMA, INC. increase (decrease) in inventories for the quarter ending 2020-03-31 was -$453.00.
- SILO PHARMA, INC. increase (decrease) in inventories for fiscal 2020 was $15.06K, a 88.36% decline from fiscal 2019.
- SILO PHARMA, INC. increase (decrease) in inventories for fiscal 2019 was $129.39K, a 379.71% increase from fiscal 2018.
- SILO PHARMA, INC. increase (decrease) in inventories for fiscal 2018 was $26.97K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2021-06-30 | $10.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $22.12K 10-Q · filed 2021-08-13 | ||
| 2021-03-31 | $11.18K 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $15.06K 10-K/A · filed 2021-05-17 | |||
| 2020-06-30 | -$975.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$1.43K 10-Q · filed 2021-08-13 | $55.36K derived: sum of 3 quarters · filed 2021-08-13 | |
| 2020-03-31 | -$453.00 10-Q · filed 2021-05-17 | $56.33K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $56.79K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | $129.39K 10-K/A · filed 2021-05-17 | ||
| 2019-09-30 | $72.61K 10-Q · filed 2019-11-13 | |||
| 2018-12-31 | $26.97K 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |